Cardiac assist devices for end-stage heart failure.
Cardiac assist devices have become an important therapy for patients with end-stage cardiac failure. These devices continue to evolve. Most current devices provide temporary, left-sided support for patients with cardiogenic shock from postcardiotomy syndrome or for patients awaiting cardiac transplantation. The two most frequently used left ventricular assist devices as a bridge to transplant are the Thermocardiosystems (HeartMate I) and the Novacor devices. The selection criteria for the use of these devices and treatment of these patients will be reviewed. Additionally, other currently available devices and future devices are also presented and discussed.
Williams
M
M
Department of Medicine, Columbia-Presbyterian Medical Center, New York, New York, USA.
Oz
M
M
Mancini
D
D
D013504:Cardiovascular Surgical Procedures / Q000295:instrumentation; D018795:Device Approval; D004867:Equipment Design; D004869:Equipment Safety; D006333:Heart Failure / Q000628:therapy*; D006353:Heart-Assist Devices / Q000592:standards; D006801:Humans; D018579:Patient Selection; D016896:Treatment Outcome; D014481:United States / Q000453:epidemiology